UBS AM’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.64M | Buy |
232,055
+72,525
| +45% | +$826K | ﹤0.01% | 2021 |
|
|
2025
Q1 | $1.9M | Buy |
159,530
+12,817
| +9% | +$152K | ﹤0.01% | 2018 |
|
|
2024
Q4 | $2.76M | Buy |
146,713
+18,189
| +14% | +$343K | ﹤0.01% | 1886 |
|
|
2024
Q3 | $2.89M | Sell |
128,524
-147
| -0.1% | -$3.3K | ﹤0.01% | 1843 |
|
|
2024
Q2 | $2.69M | Buy |
+128,671
| New | +$2.69M | ﹤0.01% | 1836 |
|
|
2023
Q4 | – | Sell |
-240,608
| Closed | -$1.89M | – | 2582 |
|
|
2023
Q3 | $1.89M | Sell |
240,608
-6,103
| -2% | -$48K | ﹤0.01% | 1659 |
|
|
2023
Q2 | $2.19M | Hold |
246,711
| – | – | ﹤0.01% | 1606 |
|
|
2023
Q1 | $2.19M | Buy |
246,711
+1,215
| +0.5% | +$10.8K | ﹤0.01% | 1606 |
|
|
2022
Q4 | $2.7M | Buy |
245,496
+14,904
| +6% | +$164K | ﹤0.01% | 1404 |
|
|
2022
Q3 | $3M | Sell |
230,592
-13,713
| -6% | -$179K | ﹤0.01% | 1390 |
|
|
2022
Q2 | $3.1M | Sell |
244,305
-8,967
| -4% | -$114K | ﹤0.01% | 1421 |
|
|
2022
Q1 | $3.55M | Sell |
253,272
-25,618
| -9% | -$359K | ﹤0.01% | 1504 |
|
|
2021
Q4 | $8.07M | Sell |
278,890
-7,209
| -3% | -$209K | ﹤0.01% | 1204 |
|
|
2021
Q3 | $8.57M | Buy |
286,099
+219
| +0.1% | +$6.56K | ﹤0.01% | 1147 |
|
|
2021
Q2 | $7.58M | Buy |
+285,880
| New | +$7.58M | ﹤0.01% | 1212 |
|